Aoshiba et al. [58] showed that intrabronchial delivery of active caspase 3 or nodularin (a serine/threonine kinase inhibitor) caused alveolar apoptosis and emphysema in rats. The gene discussed is MARK2; the disease is pulmonary emphysema.